Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial
Jean-François Korobelnik, Sergio Leal, Paolo Lanzetta, on behalf of the Korean Familial Hypercholesterolemia (KFH) Registry Investigators et autres
fr, ch, it, ar, au, at, bg, br, cn, ca, sk, cz, us, ee, ge, hu, il (code pays fourni par la source)